Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12305490 | 0.92 | TSHR (0.52) | TSHRALDH1A1KIF11CYP1A2KCNN4 | |
| Chlorotriphenylmethane SCHEMBL16781670 | 0.91 | TSHR (0.65) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL461 | 0.91 | TSHR (0.65) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL7567317 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL11237663 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL113884 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL7246540 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL29446246 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL27845684 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 | |
| Chlorotriphenylmethane SCHEMBL28253307 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP1A2KCNN4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8076492-B2 | Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil | CIPLA LIMITED (IN) | 2011-12-13 | — | — | US | disclosed |
| US-20100160643-A1 | Process for Preparing Trityl Olmesartan Medoxomil and Olmesartan Medoxomil | CIPLA LIMITED (IN) | 2010-06-24 | — | — | US | disclosed |
| EP-2074116-A2 | PROCESS FOR PREPARING TRITYL OLMESARTAN MEDOXOMIL AND OLMESARTAN MEDOXOMIL | Cipla Limited (IN) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008043996-A2 | PROCESS FOR PREPARING TRITYL OLMESARTAN MEDOXOMIL AND OLMESARTAN MEDOXOMIL | CIPLA LIMITED (IN) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160643-A1 | Process for Preparing Trityl Olmesartan Medoxomil and Olmesartan Medoxomil | MED1, AGTR1, MED12 | TSHR 1295/4885ALDH1A1 1100/4885KIF11 2642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.